Purpose Age‐related macular degeneration (AMD) is a degenerative disease of the macula,
often leading to progressive vision loss. The rate of disease progression can vary among …

Abstract Mesenchymal Stem Cells (MSCs) have been studied extensively for the treatment
of several retinal diseases. The therapeutic potential of MSCs lies in its ability to differentiate …

Biomarkers can help unravel mechanisms of disease and identify new targets for therapy.
They can also be useful in clinical practice for monitoring disease progression, evaluation of …

Background Diabetic retinopathy is a common complication of diabetes and the leading
cause of irreversible vision loss in the Western world. The reduction in color/contrast …

The use of multipotent mesenchymal stem cells (MSCs) has been reported as promising for
the treatment of numerous degenerative disorders including the eye. In retinal degenerative …

Abstract Background/Aims: The treatment options for diabetic retinopathy (DR) are limited.
Mesenchymal stem cells (MSCs) are a promising treatment option for diabetes and its …

Corneal chemical burns are common ophthalmic injuries that may result in permanent visual
impairment. Although significant advances have been achieved on the treatment of such …

Aim: To assess mesenchymal stem cells (MSCs) as carriers for HIF-1α siRNA-loaded
nanoparticles (NPs) for targeted therapy of experimental choroidal neovascularization …

Peripheral nerve injuries (PNI) occur as the result of sudden trauma and can lead to life-long
disability, reduced quality of life, and heavy economic and social burdens. Although the …

Erythropoietin (EPO) is a glycoprotein hormone conventionally thought to be responsible
only in producing red blood cells in our body. However, with the discovery of the presence of …